Skip to primary navigation
Skip to content

Scroll down or Click Here for
Important Safety Information

About EpiPen Auto-Injector
How To Use EpiPen
Allergic Emergencies Are You at Risk?
Living With Allergies
My EpiPen
Healthcare Professionals

Patient Information (PDF)
Prescribing Information (PDF)

How-to-use video

How-to-use video
Anaphylaxis
action plans
National resources

References

References:

Simons FER. Anaphylaxis: recent advances in assessment and treatment. J Allergy Clin Immunol. 2009;124(4):625-636.
Sampson HA, Munoz-Furlong A, Campbell RL, et al. Second symposium on the definition and management of anaphylaxis: summary report—Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol. 2006;117(2):391-397.
EpiPen [patient insert]. Napa, CA: Dey Pharma LP; April 2008.
Simons FER. Anaphylaxis. J Allergy Clin Immunol. 2010;125(suppl 2):S161-S181.

Download Patient Tear-Sheet

How-to-use video

To view a video on how to use the EpiPen Auto-Injector, please click below.

Email Newsletter Sign Up

Indications

EpiPen® and EpiPen® Jr Auto-Injectors (0.3 and 0.15 mg epinephrine) are indicated in the emergency treatment of type 1 allergic reactions, including anaphylaxis, to allergens, idiopathic and exercise-induced anaphylaxis, and in patients with a history or increased risk of anaphylactic reactions. Selection of the appropriate dosage strength is determined according to body weight.

Important Safety Information

EpiPen Auto-Injectors should only be injected into the anterolateral aspect of the thigh. DO NOT INJECT INTO BUTTOCK, OR INTRAVENOUSLY.

Epinephrine should be used with caution in patients with certain heart diseases, and in patients who are on drugs that may sensitize the heart to arrhythmias, because it may precipitate or aggravate angina pectoris and produce ventricular arrhythmias. Adverse reactions include transient moderate anxiety, apprehensiveness, restlessness, tremor, weakness, dizziness, sweating, palpitations, pallor, nausea and vomiting, headache, and/or respiratory difficulties.

EpiPen and EpiPen Jr Auto-Injectors are intended for immediate self-administration as emergency supportive therapy only and are not intended as a substitute for immediate medical or hospital care.

For additional information please contact us at 800-395-3376.

©2010 Dey Pharma, L.P. All rights reserved.
DEY® and the Dey logo are registered trademarks of Dey Pharma, L.P.
EpiPen®, EpiPen 2-Pak®, and EpiPen Jr 2-Pak® are registered trademarks of Mylan Inc. licensed exclusively to its wholly-owned subsidiary, Dey Pharma, L.P.
MyEpiPen™ is a trademark of Dey Pharma, L.P.

Privacy Statement
Copyright and Legal Disclaimer
Contact Us
Sitemap